Enteral Nutrition Adapted to the Nutritional Demands of Critical Illness

Fresubin^® INTENSIVE is a 1.2 kcal/ml, whey peptide-based tube feed for critically ill patients with malnutrition or malnutrition risk who have moderate protein needs combined with low-to-moderate energy needs.

A healthcare professional stands beside a patient in a hospital bed alongside Fresubin INTENSIVE, a whey peptide-based tube feed adapted to the nutritional demands of critical illness.

Enteral Nutrition Adapted to the Nutritional Demands of Critical Illness

A Formulation Adapted to Achieve Nutrition Targets in the Early Phase of Critical Illness

Fresubin INTENSIVE* has an adapted protein profile, providing 33% energy from 100% whey hydrolysate, and designed to help meet protein targets and preserve lean body mass without energy overfeeding in critically ill patients.^1-2

Nutritionally complete, clinically free from lactose and gluten, low in fibre and developed to meet the needs of critically ill patients, it is suitable as a sole source of nutrition under medical supervision.

Adapted Protein Profile

Formulated entirely from whey hydrolysate, rich in branched-chain amino acid leucine , Fresubin Intensive delivers a protein profile specifically adapted to promote anabolism.³

Modified Carbohydrate Profile

A low glycaemic index carbohydrate profile is designed to minimise blood glucose fluctuations, a key metabolic challenge in critically ill patients.^4,5

Adapted Fat Profile

With medium chain triglycerides (MCT) to support gastrointestinal tolerance and 3 g/1000 ml of EPA and DHA from fish oil to help address the stress-induced elevated needs associated with inflammation.^6,7

Designed for Intensive Care Nutrition Management

Fresubin INENSIVE has been developed for the dietary management of critically ill patients following trauma, surgery, sepsis or burns.

As a peptide-based, low-fibre formula containing whey hydrolysate and MCT, it is designed to support tolerance where digestive function is compromised, making it a practical option for the early phase of critical illness.

A patient with a nasal feeding tube lies in a hospital bed while a healthcare professional provides care, with Fresubin INTENSIVE supporting enteral nutrition in intensive care settings.

Practical Administration Within ICU

Fresubin INTENSIVE comes as a ready-to-use tube feed in a 500 ml EasyBag®.

Tube Size:
• Pump-assisted feeding: ≥ CH 8
• Gravity feeding: ≥ CH 8

Dosage: Feeding rate and daily volume to be determined by the responsible healthcare professional based on individual clinical assessment and nutritional requirements.

Fresubin® ONS

Discover our wide range of Oral Nutritional Supplements.

Fresubin® Tube Feeds

Explore Fresubin®'s Tube Feed Ranges.

Fresubin INTENSIVE factsheets can be downloaded here:

Fresubin INTENSIVE Factsheet

Filename: Fresubin_Intensive_Factsheet_HCP_viewPDF_Dec2024.pdf
Size: 7 MB
Format: pdf

*Fresubin products are food for special medical purposes, to be used under medical supervision. Fresubin Tube Feeds are suitable as sole source of nutrition. Not suitable for children under 10 years or patients with galactosaemia. Not for parenteral (I.V.) use. For Healthcare Professionals only.

References:

1 Tedeschi-Jockers F, Reinhold S, Hollinger A, Tuchscherer D, Kiss C, Gantner L, Ledergerber K, Zimmermann S, Scheuzger J, Huber J, Siegemund M. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study. Eur J Clin Nutr. 2021 Jun 24:1–9.
2 Singer P, Bendavid I, BenArie I, Stadlander L, Kagan I. Feasibility of achieving different protein targets using a hypocaloric high-protein enteral formula in critically ill patients. Crit Care. 2021 Jun 11;25(1):204. doi: 10.1186/s13054-021-03625-2.
3 Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ. Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids. 2010 May;38(5):1533-9. doi: 10.1007/s00726-009-0377-x. Epub 2009 Nov 1. PMID: 19882215.
4 Egi M et al. J Crit Care. 2010;25(1):90-6.
5 Sanz-Paris A et al. Nutrition. 2017;41:58-67.
6 Hegazi RA et al. Crit Care. 2011;15(6):234
7 McClave SA et al. JPEN J Parenter Enteral Nutr. 2016;40(2):159-211.